Key result
Optimization of ketomethylene-containing compounds provided highly active 3C protease inhibitors functioning as potent antirhinoviral agents (EC90 <1 microM) against multiple virus serotypes.
Ketomethylene-containing peptidomimetics act as potent, irreversible inhibitors of human rhinovirus 3C protease with strong antiviral activity in cell culture.
Answers are grounded in this paper and cite their sources.
These optimized inhibitors merit further preclinical testing; leaves open clinical translation for rhinovirus.
The structure-based design, chemical synthesis, and biological evaluation of various ketomethylene-containing human rhinovirus (HRV) 3C protease (3CP) inhibitors are described. These compounds are comprised of a peptidomimetic binding determinant and an ethyl propenoate Michael acceptor moiety which forms an irreversible covalent adduct with the active site cysteine residue of the 3C enzyme. The ketomethylene-containing inhibitors typically display slightly reduced 3CP inhibition activity relative to the corresponding peptide-derived molecules, but they also exhibit significantly improved antiviral properties. Optimization of the ketomethylene-containing compounds is shown to provide several highly active 3C protease inhibitors which function as potent antirhinoviral agents (EC90 = <1 microM) against multiple virus serotypes in cell culture.
No takes yet. Share an insight, caveat, or question.
Dragovich et al. (1999) studied Human rhinovirus (HRV) infection. Ketomethylene-containing human rhinovirus (HRV) 3C protease (3CP) inhibitors vs. Peptide-derived molecules was evaluated on Antiviral properties (EC90) (EC90 <1 microM). Optimization of ketomethylene-containing compounds provided highly active 3C protease inhibitors functioning as potent antirhinoviral agents (EC90 <1 microM) against multiple virus serotypes.
Synapse has enriched 10 related papers. Consider them for comparative context: